Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Trade Show

ZoomInfo Executives to Host Go-To-Market Event Series in San Francisco During Dreamforce 2023


ZoomInfo (NASDAQ: ZI), the go-to-market platform to find, acquire, and grow customers, will host a series of go-to-market (GTM) events surrounding the Dreamforce 2023 conference Sept. 12-14 in San Francisco.

Headlined by the GTM Executive Roundtable with G2, Snowflake, and Bain & Company and an AI + GTM Masterclass workshop with Anthropic, the events will feature best practices, the latest research, and hands-on experiments with leading business strategists and executives.

"We're excited to bring our GTM leadership series and AI + GTM workshop to downtown San Francisco next week," ZoomInfo CEO Henry Schuck said. "Forums like these provide crucial opportunities for exchanging ideas across industries so we can help companies gain a competitive edge as they go to market."

Wednesday's GTM roundtable will feature Schuck along with ZoomInfo CMO Bryan Law, Snowflake CMO Denise Persson, and Bain Partner Kristina Luquist in an executive session that focuses on the ever-evolving landscape of go-to-market strategies.

On Thursday, Anthropic GTM Sandy Banerjee will join Ben Salzman of ZoomInfo's GTM Strategy & ZI Labs team to put on the AI + GTM Masterclass, an immersive hands-on workshop where attendees will learn side-by-side with other industry leaders as they delve into the world of generative AI and its impact on GTM strategy.

Throughout the week, ZoomInfo will host a ZoomInfo Executive Lounge for 1:1 meetings to exchange ideas with some of the top minds in the go-to-market space, and users can visit the company's expert help desk for platform troubleshooting and demos of its latest functionality. ZoomInfo wraps up the week in San Francisco with a ping pong tournament at SPIN.

Full details:

For more information or to reserve your spot at any of these events, please visit ZoomInfo's Dreamforce 2023 landing page.

About ZoomInfo

ZoomInfo (NASDAQ: ZI) is the trusted go-to-market platform for businesses to find, acquire, and grow their customers. It delivers accurate, real-time data, insights, and technology to more than 35,000 companies worldwide. Businesses use ZoomInfo to increase efficiency, consolidate technology stacks, and align their sales and marketing teams ? all in one platform. ZoomInfo is a recognized leader in data privacy, with industry-leading GDPR and CCPA compliance and numerous data security and privacy certifications. For more information about how ZoomInfo can help businesses grow their revenue at scale, please visit www.zoominfo.com.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: